Abstract
Human embryonic stem cells (hESCs) are pluripotent cells derived from the embryo at the blastocyst stage. Their embryonic origin confers upon them the capacity to proliferate indefinitely in vitro while maintaining the capacity to differentiate into a large variety of cell types. Based on these properties of self-renewal and pluripotency, hESCs represent a unique source to generate a large quantity of certain specialized cell types with clinical interest for transplantation-based therapy. However, hESCs are usually grown in culture conditions using fetal bovine serum and mouse embryonic fibroblasts, two components that are not compatible with clinical applications. Consequently, the possibility to expand hESCs in serum-free and in feeder-free culture conditions is becoming a major challenge to deliver the clinical promises of hESCs. Here, we describe the basic principles of growing hESCs in a chemically defined medium (CDM) devoid of serum and feeders.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J., Marshall, V.S., et al. (1998) Embryonic stem cell lines derived from human blastocysts. Science 282, 1145–1147.
Amit, M., Carpenter, M.K., Inokuma, M.S., Chiu, C.P., Harris, C.P., Waknitz, M.A., et al. (2000) Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271–278.
Xu, R.H., Peck, R.M., Li, D.S., Feng, X., Ludwig, T., and Thomson, J.A. (2005) Basic FGF and suppression of BMP signaling sustain undifferentiated proliferation of human ES cells. Nat. Methods 2, 185–190.
Xu, C., Inokuma, M.S., Denham, J., Golds, K., Kundu, P., Gold, J.D., et al. (2001) Feeder-free growth of undifferentiated human embryonic stem cells. Nat. Biotechnol. 19, 971–974.
Rosler, E.S., Fisk, G.J., Ares, X., Irving, J., Miura, T., Rao, M.S., et al. (2004) Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229, 259–274.
Vallier, L., Reynolds, D., and Pedersen, R.A. (2004) Nodal inhibits differentiation of human embryonic stem cells along the neuroectodermal default pathway. Dev. Biol. 275, 403–421.
Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., and Brivanlou, A.H. (2004) Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat. Med. 10, 55–63.
Vallier, L., Alexander, M., and Pedersen, R.A. (2005) Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell. Sci. 118, 4495–4509.
James, D., Levine, A.J., Besser, D., and Hemmati-Brivanlou, A. (2005) TGFbeta/activin/nodal signaling is necessary for the maintenance of pluripotency in human embryonic stem cells. Development 132, 1273–1282.
Levenstein, M.E., Ludwig, T.E., Xu, R.H., Llanas, R.A., VanDenHeuvel-Kramer, K., Manning, D., et al. (2006) Basic fibroblast growth factor support of human embryonic stem cell self-renewal. Stem Cells 24, 568–574.
Ludwig, T.E., Bergendahl, V., Levenstein, M.E., Yu, J., Probasco, M.D., and Thomson, J.A. (2006) Feeder-independent culture of human embryonic stem cells. Nat. Methods 3, 637–646.
Brons, I.G., Smithers, L.E., Trotter, M.W., Rugg-Gunn, P., Sun, B., Chuva de Sousa Lopes, S.M., et al. (2007) Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature 448, 191–195.
Ludwig, T.E., Levenstein, M.E., Jones, J.M., Berggren, W.T., Mitchen, E.R., Frane, J.L., et al. (2006) Derivation of human embryonic stem cells in defined conditions. Nat. Biotechnol. 24, 185–187.
Yao, S., Chen, S., Clark, J., Hao, E., Beattie, G.M., Hayek, A., et al. (2006) Long-term self-renewal and directed differentiation of human embryonic stem cells in chemically defined conditions. Proc. Natl. Acad. Sci. U.S.A. 103, 6907–6912.
Lu, J., Hou, R., Booth, C.J., Yang, S.H., and Snyder, M. (2006) Defined culture conditions of human embryonic stem cells. Proc. Natl. Acad. Sci. U.S.A. 103, 5688–5693.
Furue, M.K., Na, J., Jackson, J.P., Okamoto, T., Jones, M., Baker, D., et al. (2008) Heparin promotes the growth of human embryonic stem cells in a defined serum-free medium. Proc. Natl. Acad. Sci. USA 105, 13409–13414.
Dravid, G., Ye, Z., Hammond, H., Chen, G., Pyle, A., Donovan, P., et al. (2005) Defining the role of Wnt/beta-catenin signaling in the survival, proliferation, and self-renewal of human embryonic stem cells. Stem Cells 23, 1489–1501.
Melchior, K., Weiss, J., Zaehres, H., Kim, Y.M., Lutzko, C., Roosta, N., et al. (2008) The WNT receptor FZD7 contributes to self-renewal signaling of human embryonic stem cells. Biol. Chem. 389, 897–903.
Bendall, S.C., Stewart, M.H., Menendez, P., George, D., Vijayaragavan, K., Werbowetski-Ogilvie, T., et al. (2007) IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature 448, 1015–1021.
Osafune, K., Caron, L., Borowiak, M., Martinez, R.J., Fitz-Gerald, C.S., Sato, Y., et al. (2008) Marked differences in differentiation propensity among human embryonic stem cell lines. Nat. Biotechnol. 26, 313–315.
Rajala, K., Hakala, H., Panula, S., Aivio, S., Pihlajamaki, H., Suuronen, R., et al. (2007) Testing of nine different xeno-free culture media for human embryonic stem cell cultures. Hum. Reprod. 22, 1231–1238.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Vallier, L. (2011). Serum-Free and Feeder-Free Culture Conditions for Human Embryonic Stem Cells. In: Nieden, N. (eds) Embryonic Stem Cell Therapy for Osteo-Degenerative Diseases. Methods in Molecular Biology, vol 690. Humana Press. https://doi.org/10.1007/978-1-60761-962-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-60761-962-8_3
Published:
Publisher Name: Humana Press
Print ISBN: 978-1-60761-961-1
Online ISBN: 978-1-60761-962-8
eBook Packages: Springer Protocols